FRANCISCO J. DE LA
SERNA TORROBA

Profesor asociado de Ciencias de la Salud

Foto de FRANCISCO J. DE LA

Foto de Hospital Universitario Marqués de Valdecilla

Hospital Universitario Marqués de Valdecilla

Santander, España

Publicaciones en colaboración con investigadores/as de Hospital Universitario Marqués de Valdecilla (4)

2024

Ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL): GELLC-7 trial from the Spanish group of CLL (GELLC)
eClinicalMedicine, Vol. 73

2021

Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM)
PLoS ONE, Vol. 16, Núm. 9 September

2016

Toxicity and efficacy of busulfan and fludarabine myeloablative conditioning for HLA-identical sibling allogeneic hematopoietic cell transplantation in AML and MDS
Bone Marrow Transplantation, Vol. 51, Núm. 7, pp. 961-966

2003

Tandem transplants with different high-dose regimens improve the complete remission rates in multiple myeloma. Results of a Grupo Español de Síndromes Linfoproliferativos/Trasplante Autólogo de Médula Ósea phase II trial
British Journal of Haematology, Vol. 120, Núm. 2, pp. 296-303